We are live on ! Find out more
PBH icon

Prestige Consumer Healthcare

230 hedge funds and large institutions have $2.11B invested in Prestige Consumer Healthcare in 2019 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 69 increasing their positions, 85 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

112% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 17

8% more funds holding

Funds holding: 212230 (+18)

7% more capital invested

Capital invested by funds: $1.96B → $2.11B (+$147M)

1.3% more ownership

Funds ownership: 119.53%120.83% (+1.3%)

19% less repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 85

68% less call options, than puts

Call options by funds: $392K | Put options by funds: $1.21M

Holders
230
Holders Change
+18
Holders Change %
+8.49%
% of All Funds
5.04%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
36
Increased
69
Reduced
85
Closed
17
Calls
$392K
Puts
$1.21M
Net Calls
-$821K
Net Calls Change
-$920K
Name Holding Trade Value Shares
Change
Change in
Stake
OPERF
126
Oregon Public Employees Retirement Fund
Oregon
$734K +$13.5K +410 +2%
Morgan Stanley
127
Morgan Stanley
New York
$710K +$337K +10,239 +100%
CEP
128
Chicago Equity Partners
Illinois
$692K -$961K -29,185 -59%
AA
129
Ancora Advisors
Ohio
$675K +$133K +4,040 +26%
Envestnet Asset Management
130
Envestnet Asset Management
Illinois
$668K +$278K +8,449 +78%
MAM
131
Meeder Asset Management
Ohio
$665K -$110K -3,339 -15%
Pacer Advisors
132
Pacer Advisors
Pennsylvania
$664K -$48.1K -1,461 -7%
TCOV
133
Trust Company of Vermont
Vermont
$658K +$625K +18,968 New
Balyasny Asset Management
134
Balyasny Asset Management
Illinois
$654K +$621K +18,856 New
EP
135
Elkfork Partners
Oregon
$650K
AIP
136
Ameritas Investment Partners
Nebraska
$643K -$35.8K -1,086 -6%
Bessemer Group
137
Bessemer Group
New Jersey
$626K +$594K +18,043 New
GAM
138
Gotham Asset Management
New York
$620K -$244K -7,421 -29%
SFM
139
Systematic Financial Management
New Jersey
$591K -$416K -12,620 -43%
GHCM
140
Glen Harbor Capital Management
California
$535K
HF
141
HRT Financial
New York
$515K +$490K +14,868 New
SOMRS
142
State of Michigan Retirement System
Michigan
$506K -$23.1K -700 -5%
NMIMC
143
Northwestern Mutual Investment Management Company
Wisconsin
$497K -$14.7K -447 -3%
AG
144
Algert Global
California
$486K -$468K -14,198 -50%
TEE
145
Tibra Equities Europe
United Kingdom
$465K +$441K +13,400 New
Thrivent Financial for Lutherans
146
Thrivent Financial for Lutherans
Minnesota
$452K -$21.4K -649 -5%
JMPWA
147
JP Morgan Private Wealth Advisors
California
$452K +$103K +3,131 +32%
P
148
Pitcairn
Pennsylvania
$450K +$24.9K +757 +6%
PAM
149
Panagora Asset Management
Massachusetts
$430K
LSERS
150
Louisiana State Employees Retirement System
Louisiana
$420K -$36.2K -1,100 -8%

PBH Hedge Fund Activity: Q3 2019 in Review

230 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q3 2019, worth a combined $2.11B — up 7.5% from $1.96B a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new PBH positions and 17 closed out — a net gain of 19 holders — while 69 added to existing stakes and 85 trimmed.

The largest buyer was BlackRock, adding an estimated $9.11M. The largest seller was ArrowMark Colorado Holdings, cutting an estimated $36M.

  • 230 institutional investors held Prestige Consumer Healthcare (PBH) as of Q3 2019, up from 212 in Q2 2019.
  • Funds reported $2.11B of Prestige Consumer Healthcare stock for Q3 2019, up 7.5% quarter-over-quarter.
  • 36 funds opened new Prestige Consumer Healthcare positions in Q3 2019 and 17 closed out, a net change of +19 holders.
  • The largest Prestige Consumer Healthcare buyer in Q3 2019 was BlackRock, an estimated $9.11M added.
  • The largest Prestige Consumer Healthcare seller in Q3 2019 was ArrowMark Colorado Holdings, an estimated $36M sold.

Based on aggregated 13F filings for Q3 2019.